Rundu Pharma(SZ:002923) Xin Lang Cai Jing·2025-12-31 03:24Group 1 - The core viewpoint of the news is that Zhuhai Runduo Pharmaceutical Co., Ltd. has shown a slight increase in stock price, with a current trading price of 12.15 yuan per share and a total market capitalization of 4.069 billion yuan [1] - The company was established on December 30, 1999, and went public on January 5, 2018. Its main business involves the research, production, and sales of chemical drug formulations, chemical raw materials, and pharmaceutical intermediates [1] - The revenue composition of the company is as follows: formulations account for 56.18%, raw materials 40.79%, intermediates 1.83%, and others 1.20% [1] Group 2 - Among the top ten circulating shareholders of Runduo Pharmaceutical, Huashang Fund's Huashang Selected Return Mixed A (010761) reduced its holdings by 32,300 shares in the third quarter, now holding 1.5833 million shares, which is 0.61% of the circulating shares [2] - The fund has achieved a year-to-date return of 49.23%, ranking 1269 out of 8085 in its category, and a one-year return of 47.32%, ranking 1222 out of 8085 [2] Group 3 - The fund manager of Huashang Selected Return Mixed A includes Yu Yi, Sun Wei, and Cui Zhipeng, with varying tenures and performance records [3] - Yu Yi has a tenure of 3 years and 111 days, with the best fund return of 81.1% during this period [3] - Sun Wei has a tenure of 2 years and 363 days, with a best return of 70.94% [3] - Cui Zhipeng has a tenure of 1 year and 364 days, with a best return of 72.4% [3]